ACADIA PHARMACEUTICALS for ACADIA PHARMACEUTICALS
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Implementation of the Inflation Reduction Act of 2022; Orphan Cures Act (HR 946); National Plan to End Parkinsons Act (Public Law 118-66, 118th Congress); Give Kids A Chance (HR1262); Cameron's Law (HR1414).
| Lobbyist | Covered position, as disclosed |
|---|---|
| MICHAEL MATTOON | — |
Medicare/Medicaid MMM
Implementation of the Inflation Reduction Act of 2022; Issues related to protecting patient access to medicines in Medicare; Issues related to access to medicines for Parkinson's disease patients; Issues related to Antipsychotic use in Medicare; Orphan Cures Act (HR 946); National Plan to End Parkinsons Act (Public Law 118-66, 118th Congress); EPIC Act (HR 1492).
| Lobbyist | Covered position, as disclosed |
|---|---|
| MICHAEL MATTOON | — |
Taxation/Internal Revenue Code TAX
Cameron's Law (HR 14114)
| Lobbyist | Covered position, as disclosed |
|---|---|
| MICHAEL MATTOON | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.